A preliminary study on plasma concentration, short-term efficacy, and safety profile of dolutegravir in Chinese people with HIV-Reference-Cited by-同舟云学术

A preliminary study on plasma concentration, short-term efficacy, and safety profile of dolutegravir in Chinese people with HIV

Published:2024-01-26 Issue:7 Volume:17 Page:625-631
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Li Dongsheng¹²,Xiao Ran¹,Fu Qiang¹,Song Xiaojing³,Han Yang³,Du Xiaoli¹,Li Taisheng³⁴⁵

Affiliation:

1. Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

3. Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4. School of Medicine, Tsinghua University, Beijing, China

5. State Key Laboratory for Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Beijing, China

Funder

Special Research Fund for the Central High-level Hospitals of Peking Union Medical College Hospital, Beijing, China

Chinese Academy of Medical Sciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2308664

Reference23 articles.

1. HIV/AIDS late presentation and its associated factors in China from 2010 to 2020: a systematic review and meta-analysis

2. WHO Guidelines Approved by the Guidelines Review Committee. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021.

3. Development and validation of an HPLC method for quantification of dolutegravir in human plasma

4. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race